Lyell Immunopharma, Inc. (LYEL)
34.67
+1.26
(+3.77%)
USD |
NASDAQ |
Dec 12, 16:00
34.67
0.00 (0.00%)
After-Hours: 20:00
Lyell Immunopharma Market Cap: 513.40M for Dec. 12, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 13.09B |
| AnaptysBio, Inc. | 1.242B |
| Ovid Therapeutics, Inc. | 117.14M |
| Cogent Biosciences, Inc. | 6.460B |
| NovaBay Pharmaceuticals, Inc. | 354.09M |
Market Cap Related Metrics
| PS Ratio | 125720.5 |
| PEG Ratio | -0.0007 |
| Price to Book Value | 1.560 |
| Price | 34.67 |
| Earnings Yield | -56.51% |
| PEGY Ratio | -0.0007 |